Norwich Makes Major Investment In Pilot Scale Production Facility

Norwich Pharmaceuticals, Inc., an industry leader in contract manufacturing and packaging, has recently completed a major capital investment in infrastructure, controls and the specialized equipment necessary to support the pilot scale formulation and Clinical Trial Material (CTM) manufacture of new and existing pharmaceutical products.

The addition of these small-scale services is a major expansion on the part of the New York-based company, which has served the pharmaceutical industry for over 100 years. Prior to this investment in new product formulation, Norwich concentrated its scope of services in commercial-scale manufacturing and packaging. The company?s expansion into new product development required the investment into their pilot-scale equipment and facilities, and signals the aggressiveness with which Norwich is approaching its role in the future of outsourcing services.

As Norwich president, Chris Calhoun indicated, ?Small scale development studies require a broad range of equipment.? stated Calhoun. ?We invested in new, state-of-the-art particle sizing equipment, tablet compression equipment, high shear granulation, fluid bed and mixers with capacities in line with the requirements of formulation activities.?

?Our engineers have been diligently comparing the specifications of equipment?, said Calhoun, ?making certain that what we were putting in place could be scalable and adaptable to meet the varied requirements of several pilot programs at one time.?

In addition to the capital investment in equipment and physical infrastructure, Norwich has been attracting top-level industry executives and project management personnel to advance its role in new product development. ?We?ve put together an exceptional technical team,? said Calhoun. ?We?re now in a position to help plan and launch more new initiatives, and then assist our clients throughout the life cycle of a successful product.?

Through a selective build-up of personnel and major capital investments it appears that Norwich is committed to an increasing its role in the future of biopharmaceutical development as more and more manufacturers seek state-of-the-art, full-service outsourcing capabilities.

About Norwich Pharmaceuticals, Inc.
Norwich Pharmaceuticals, Inc., based in Norwich, NY, provides comprehensive support services to the pharmaceutical industry on an outsourcing basis ? from clinical trial, through scale-up, to commercial launch. The company brings over 100 years of experience to the manufacture, packaging, associated quality services, and distribution of solid dose, semi-solid, and liquid pharmaceutical products.

For more information contact Chris Calhoun, President of Norwich Pharmaceuticals at chris.calhoun ( @ ) norwichpharma dot com or call 888-674-7979.


Contact Details

Company Name: Ed Delia
Issued By: Ed Delia
Phone: 908-534-9044
Address: 295 Route 22 East
Zip: 08888
Website: Visit the website

by Ed Delia (few years ago!)

Latest Press Releases

The Mad Hatter Now Offer a Full Line of Hearth Products and Full Line of Grills

Diabetes Insulin Delivery Pens Market Research Report 2018

Dr Kapadia Provides Tips to Patients Interested in Hair Transplant Procedures

love vashikaran specialist

Solar Blanket Sales Market Report 2018

Spring Bottled Water Market Insights, Forecast to 2025

Biochemical Incubator Sales Market Report 2018

Quinine Sulphate Sales Market Report 2018

Automotive Chassisc System Market Insights, Forecast to 2025

2,6-Dicarboxypyridine market size in key regions like North America, Europe, Asia Pacific an..

Remove this press release ?

Due to extra work required to remove the press-releases we have started charging $1.99 for press release removal.

Your press release will be removed in 24 hours, once the payment has been received.

Search Press Release
e.g. Business, Computer, etc.